ProQR Therapeutics (NASDAQ:PRQR) Posts Earnings Results, Misses Expectations By $0.01 EPS
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.01), FiscalAI reports. The firm had revenue of $5.50 million for the quarter, compared to the consensus estimate of $6.12 million. ProQR […]
13 Mar 13:30 · The Cerbat Gem